Charles Schwab’s Vivani Medical VANI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30K Hold
30,016
﹤0.01% 3445
2025
Q4
$36.9K Hold
30,016
﹤0.01% 3437
2025
Q3
$42.3K Hold
30,016
﹤0.01% 3436
2025
Q2
$38.7K Hold
30,016
﹤0.01% 3465
2025
Q1
$31.5K Hold
30,016
﹤0.01% 3436
2024
Q4
$34.8K Hold
30,016
﹤0.01% 3460
2024
Q3
$35.1K Sell
30,016
-1
-0% -$1 ﹤0.01% 3448
2024
Q2
$37.8K Hold
30,017
﹤0.01% 3541
2024
Q1
$55.5K Hold
30,017
﹤0.01% 3358
2023
Q4
$30.6K Hold
30,017
﹤0.01% 3446
2023
Q3
$30.6K Hold
30,017
﹤0.01% 3465
2023
Q2
$36.3K Buy
+30,017
New +$37K ﹤0.01% 3470
2022
Q3
Sell
-5,513
Closed -$34K 3550
2022
Q2
$34K Buy
+5,513
New +$29.7K ﹤0.01% 3453
2017
Q2
Sell
-5,865
Closed -$171K 3141
2017
Q1
$171K Buy
5,865
+3,921
+202% +$150K ﹤0.01% 2955
2016
Q4
$92K Buy
1,944
+128
+7% +$7.31K ﹤0.01% 3045
2016
Q3
$154K Buy
1,816
+108
+6% +$9.56K ﹤0.01% 2967
2016
Q2
$147K Buy
1,708
+173
+11% +$18K ﹤0.01% 3013
2016
Q1
$178K Buy
1,535
+34
+2% +$3.91K ﹤0.01% 2921
2015
Q4
$213K Buy
1,501
+817
+119% +$120K ﹤0.01% 2951
2015
Q3
$98K Hold
684
﹤0.01% 3034
2015
Q2
$224K Buy
+684
New +$219K ﹤0.01% 2960

Other funds holding VANI

Charles Schwab's VANI Position: Q1 2026 in Review

Charles Schwab held its Vivani Medical (VANI) position steady in Q1 2026 at 30,016 shares worth $30K. The position accounts for ﹤0.01% of the portfolio, ranked #3445.

Charles Schwab first reported a position in VANI in Q2 2015 and has held it in 21 quarters since. The position peaked at $224K in Q2 2015. 43 funds tracked by Wall St. Rank hold VANI as of Q1 2026.

  • Charles Schwab held 30,016 shares of Vivani Medical worth $30K as of Q1 2026.
  • Charles Schwab left its Vivani Medical share count unchanged in Q1 2026.
  • Vivani Medical made up ﹤0.01% of Charles Schwab's portfolio in Q1 2026, its #3445 holding.
  • Charles Schwab first reported a position in Vivani Medical in Q2 2015 and has held it in 21 quarters since.
  • Charles Schwab's Vivani Medical position peaked at $224K in Q2 2015.
  • 43 funds tracked by Wall St. Rank held Vivani Medical as of Q1 2026.

Based on Charles Schwab's 13F filing for Q1 2026, filed 15 May 2026.